Results 281 to 290 of about 249,915 (344)
Robot-assisted versus video-assisted thoracoscopic thymectomy for stage I-II thymic epithelial tumour: a protocol for the first multicentre, randomised controlled clinical trial. [PDF]
Wang S+14 more
europepmc +1 more source
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri+12 more
wiley +1 more source
Single-Anesthesia Event for Lung Nodule Marking and Minimally Invasive Sublobar Resection. [PDF]
Gordon N+7 more
europepmc +1 more source
AIM This analysis provides a comparison of the efficacy of initial mono and combination therapy in patients with PAH and cardiovascular comorbidities or with risk factors of HFpEF (heart failure with preserved ejection fractioin).METHOD Data from the European COMPERA registry were used for a matched pair analysis.
Dirk Skowasch+20 more
wiley +1 more source
Posterior tibial artery pseudoaneurysm: a rare complication following orthopedic surgery-a case report. [PDF]
Bodart E.
europepmc +1 more source
Abstract Aims Cardiopulmonary bypass (CPB) is the standard approach for coronary artery bypass grafting (CABG) in advanced ischaemic cardiomyopathy. Microaxial pump support has been envisioned to allow for beating‐heart CABG without CPB (MPCAB), thereby avoiding CPB‐inherent complications.
Anna Kathrin Assmann+5 more
wiley +1 more source
A three-dimensional model of aortic dissection for hybrid surgical simulation and training. [PDF]
Arakawa M, Kawahito K.
europepmc +1 more source
Abstract Sodium‐glucose cotransporter‐2 (SGLT2) inhibitors represent one of the main cornerstones of heart failure treatment. Nevertheless, while the cardiovascular beneficial effects of these drugs have been clearly demonstrated by several clinical trials, in clinical practice, it remains challenging to identify the appropriate timing to start SGLT2 ...
Ruggero Mazzotta+10 more
wiley +1 more source
Is It Safe to Omit Any Chest X-Ray Before Removing the Chest Drain After Elective, Non-Cardiac Thoracic Surgery? A Single-Center, Retrospective, Case-Control Study. [PDF]
Karampinis I+6 more
europepmc +1 more source
Angiotensin receptor/Neprilysin inhibitors (ARNI) have shown to considerably improve the clinical outcome of patients with heart failure and reduced ejection fraction (HFrEF). Identifying individuals who may benefit from ARNI the most could markedly enhance patient management.
Maria Concetta Pastore+15 more
wiley +1 more source